The trials and tribulations of IL-5, eosinophils, and allergic asthma
- 1 October 2001
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 108 (4), 503-508
- https://doi.org/10.1067/mai.2001.119149
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Airway eosinophilia is not a requirement for allergen‐induced airway hyperresponsivenessClinical and Experimental Allergy, 2000
- Repeatability of allergen-induced airway inflammationJournal of Allergy and Clinical Immunology, 1999
- Therapeutic efficacy of an anti–IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugsJournal of Allergy and Clinical Immunology, 1998
- Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.JCI Insight, 1997
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- Reproducibility of allergen-induced early and late asthmatic responsesJournal of Allergy and Clinical Immunology, 1995
- The biological role of interleukin 5The International Journal of Cell Cloning, 1990
- Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholineJournal of Allergy and Clinical Immunology, 1989
- Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients+Journal of Allergy and Clinical Immunology, 1986